Supply of Menveo meningococcal conjugate vaccine by Novartis Vaccines and Diagnostics Pty Ltd

Administered by Department of Health, Disability and Ageing

Legislation au C2013G00069 In force Gazette

Legislation content

COMMONWEALTH OF AUSTRALIA

 

THERAPEUTIC GOODS ACT 1989

 

SECTION 14 AND 14A NOTICE

 

 

On 19 December 2012 the delegate of the Secretary of the Department of Health and Ageing for the purposes of sections 14 and 14A of the Therapeutic Goods Act 1989 (“the Act”) gave consent to the following:

 

(a)   the supply by Novartis Vaccines and Diagnostics Pty Ltd, 54 Waterloo Road North Ryde NSW 2113 (the Company) of MENVEO meningococcal conjugate vaccine; AND

 

(b)  for the above goods not to conform with the requirements of clause 3(2)(b) and 3(2)(c) of the Therapeutic Goods Order No 69 - “General Requirements for Labels for Medicines” in that the name and quantity of the active ingredients are not listed on the vial labels.

 

 

 

 

 

 

 

 

 

 

 

 

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.